🌤️ Mood & stress resilience

What actually decides this outcome, in order of size

Nothing on this shelf outranks the first three items, and two of them cost nothing. Ranked by how much of the outcome each one owns:

1. Whether this is a clinical situation rather than an optimization one, which is the question this page cannot answer and will not pretend to. Low mood that has lasted weeks, that is worsening, that comes with hopelessness, or that includes any thought of self-harm is a reason to speak to a doctor or a crisis service today. Nothing on this page is a diagnosis, a treatment or a substitute for that conversation, and the rest of the ranking below assumes it has already happened.
2. Sleep, which sits upstream of every pathway here. It is not for sale on this goal, it changes the mood literature in both directions, and it has its own estate at Sleep better. A person sleeping five hours is not a person with a neurotransmitter problem yet.
3. Physical activity, which has randomized trial evidence pooled across protocols Correia 2023 and no supplement here can match. That is not a motivational statement. It is the observation that the best-evidenced non-prescription intervention on this goal is free, and that a page selling capsules beside it owes the reader that sentence.
4. The exclusions, because four of them present as low mood and are on one requisition. Thyroid disease is common at population scale Hollowell 2002; iron deficiency without anemia produces fatigue and flat affect; B12 and folate shortfalls produce a picture that no receptor pharmacology fixes; and vitamin D status is worth knowing for reasons that are not specific to mood Kahwati 2021.
5. Whether inflammation is in the picture, because it changes which pathway to try first. Cytokine exposure produces depressive symptoms directly, and imaging work in people receiving interferon and anti-TNF therapies shows the neural correlates rather than only the questionnaire ones Davies 2021. Where mood tracks with illness, gut symptoms or an autoimmune diagnosis, Inflammation & the cytokine route to low mood comes before the monoamine pathways.
6. What else is already being taken, because the largest safety issue on this goal is an interaction rather than an ingredient. Anything serotonergic on top of a prescribed serotonergic is the one combination on this page that can put somebody in hospital.
7. The compounds, last, and their evidence is not one grade. A standardized lavender oil preparation has a meta-analysis of randomized placebo-controlled trials in anxiety disorders Dold 2023; chamomile has a randomized trial in generalized anxiety Amsterdam 2009; passionflower has a randomized study Harit 2024; theanine has a critical review that separates the science from the marketing Dashwood 2025.

The order to run these in, and what has to be true first

Exclusions, then the free levers, then one pathway at a time with enough weeks to judge it. Adaptogens and botanicals on this goal are slow, which makes stacking three of them at once the fastest way to learn nothing.

1. A clinical conversation first if any of the flags above apply, and one requisition second. TSH (Thyroid-Stimulating Hormone) with Free T4 (Thyroxine), Ferritin, Vitamin B12 with Folate, RBC, Vitamin D (25-Hydroxy), hs-CRP (High-Sensitivity C-Reactive Protein) and HbA1c (Hemoglobin A1c). Add Homocysteine if the methylation pathway is being considered.
2. Sleep and movement before any purchase, for eight weeks. The pooled randomized evidence for exercise is the strongest thing on this goal that does not require a prescription Correia 2023, and measuring the eight weeks matters because everything below is judged against whatever this leaves behind.
3. Then correct what the panel found, and only what it found. Methylation & micronutrient substrate exists for exactly this: Methylfolate (5-MTHF), Methylcobalamin (B12) and Vitamin B6 (P5P) are substrate corrections rather than mood drugs, and correcting a normal value does nothing.
4. If the pattern is wired and tired rather than flat, start with the axis. HPA axis & cortisol regulation holds Ashwagandha, Rhodiola and Phosphatidylserine, and these are measured in weeks because they act on a regulatory axis rather than on a receptor.
5. If the pattern is acute anxiety, the calming pathway is the one, and it is also the one with the dependence risk. GABAergic & calming. Lavender Oil (Silexan) has the best randomized base in that pathway Dold 2023 and does not act at the benzodiazepine site; Phenibut is at the other end and produces physical dependence with a withdrawal syndrome documented in case series Ahuja 2018.
6. If mood tracks with illness or gut symptoms, take the inflammatory route before the monoamine one. Inflammation & the cytokine route to low mood, on the reasoning that cytokine exposure changes mood-relevant neural responses Davies 2021.
7. Serotonergic last, and only with the interaction question answered. Serotonergic. If a prescription serotonergic is already in place, this pathway is a conversation with the prescriber rather than a purchase. Pregnenolone sits oddly in this estate and is worth reading honestly: it has a randomized placebo-controlled trial in bipolar depression Brown 2014, which is a specific population and not a general mood indication.

What gets bought for this that cannot move it

The model that fails structurally is the serotonin-deficiency story used as a shopping list. If low mood were a shortage of one monoamine, supplying its precursor would be reliable and it is not. The pathways on this goal act on an axis, on cytokine signaling, on inhibitory tone and on cofactor availability, and those are four different problems that produce the same questionnaire score. Buying from the wrong one of them is the commonest failure here, and it is invisible because the score is the only instrument.

The surrogate problem on this goal is sharper than anywhere else on the site. The endpoint is a scale, the scale is a structured description of how somebody feels, and expectation moves it. That is not an argument against the scales; they are the correct instrument and the trials cited here used them Correia 2023 Amsterdam 2009. It is an argument for the design: a randomized comparison against placebo is worth far more here than in most of the estate, and an uncontrolled personal trial is worth far less. Where a physical correlate exists, it is worth having, which is why the imaging work beside the cytokine model is more informative than another questionnaire Davies 2021.

Two specific safety failures. Combining anything serotonergic with a prescribed serotonergic is the interaction that matters most on this page. And Phenibut is the compound most casually recommended online and the one with the clearest dependence and withdrawal record Ahuja 2018; it belongs in a discussion about risk, not in a starter stack.

If the goal underneath is different, so is the page. Low mood that is really exhaustion is Energy & fatigue. Low mood that arrives in the second half of every cycle is Luteal phase & progesterone support. Low mood with cold intolerance and weight change is Thyroid & metabolic rate. And if the difficulty is thoughts of self-harm, that is a doctor or a crisis line today rather than any page, product or protocol on this site.

How you would know it was working, on a real read-out and a real timescale

This page makes two predictions. The exclusion panel will reclassify a real fraction of readers off the monoamine pathways entirely, because thyroid, iron and B12 problems present as this goal Hollowell 2002; and any botanical here that is going to work will declare itself within the window its own trials used, which is four to eight weeks rather than four to eight days.

• TSH (Thyroid-Stimulating Hormone) with Free T4 (Thyroxine), Ferritin, Vitamin B12 and Folate, RBC at baseline. These four are the exclusions. Repeat only what was abnormal, at 12 weeks, because red cell folate and ferritin both integrate over months rather than days.
• hs-CRP (High-Sensitivity C-Reactive Protein) at baseline, and again at 8 weeks if the inflammatory route is the one being taken. A raised value alongside low mood is the observation that justifies that pathway Davies 2021, and a normal one is a reason to try a different pathway first.
• Homocysteine once, if the methylation pathway is being considered. It is the functional read-out of that cycle, and it responds to B12, folate and B6 status rather than to how anybody feels.
• Vitamin D (25-Hydroxy) at baseline and 12 weeks after a dose change. Twelve weeks because of the circulating half-life Kahwati 2021, not because of any mood timescale.
• A validated self-report scale, scored the same way, on the same day of the week, at baseline and every four weeks. This is the endpoint the trials used and it is the endpoint that matters; scoring it on a fixed schedule rather than on bad days is what makes it a measurement instead of a mood diary.

What will fool you. Mood is seasonal, and a supplement started in February will be credited with spring. Placebo response in this literature is large, which is why the controlled trials cited here carry weight and a personal before-and-after does not Dold 2023. Anything sedating improves a sleep item and moves a total score without touching the rest of it. Alcohol lowers mood on a two-day lag, so a weekend distorts a Monday score. And stopping a prescribed antidepressant to test a supplement is dangerous and is a decision for a prescriber, not for a page.

Sources read for these sections

• Correia EM. Analysis of the Effect of Different Physical Exercise Protocols on Depression in Adults: Systematic Review and Meta-analysis of Randomized Controlled Trials. Sports Health 2023 · PMID 37994044
• Dold M. Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials. European Archives of Psychiatry and Clinical Neuroscience 2023 · PMID 36717399
• Davies KA. Interferon and anti-TNF therapies differentially modulate amygdala reactivity which predicts associated bidirectional changes in depressive symptoms. Molecular Psychiatry 2021;26(9):5150-5160 · PMID 32457424
• Hollowell JG, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994). Journal of Clinical Endocrinology and Metabolism 2002 · PMID 11836274
• Amsterdam JD, Li Y, et al. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. Journal of Clinical Psychopharmacology 2009 · PMID 19593179
• Harit MK. Randomized, Double-Blind, Placebo-Controlled, Clinical Study of Passiflora incarnata in Participants With Stress and Sleep Problems. Cureus 2024 · PMID 38646244
• Dashwood R, et al. l-theanine: From tea leaf to trending supplement - does the science match the hype for brain health and relaxation?. Nutrition Research 2025 · PMID 39854799
• Ahuja T, et al. Phenibut (beta-Phenyl-gamma-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse. Case Reports in Psychiatry 2018 · PMID 29854531
• Kahwati LC. Screening for Vitamin D Deficiency in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2021;325(14):1443-1463 · PMID 33847712
• Brown ES, et al. A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression. Neuropsychopharmacology 2014;39(12):2867-2873 · PMID 24917198